(Q37342244)

19 August 2017

1 reference

title

Risk-benefit assessment of drugs used for the treatment of menstrual disorders (English)

1 reference

19 August 2017

1 reference

J M Higham

1

1 reference

19 August 2017

R W Shaw

series ordinal

2

1 reference

19 August 2017

publication date

1 May 1991

1 reference

19 August 2017

1 reference

19 August 2017

volume

6

1 reference

19 August 2017

issue

3

1 reference

19 August 2017

page(s)

183-191

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-199106030-00004

19 August 2017

exact match

0 references

cites work

Treatment of dysfunctional uterine bleeding with danazol

1 reference

12 December 2020

Do British women undergo too many or too few hysterectomies?

1 reference

12 December 2020

Studies in menorrhagia: (a) mefenamic acid, (b) endometrial prostaglandin concentrations

1 reference

12 December 2020

Clinical experience with norethisterone and norethisterone acetate

1 reference

12 December 2020

Effect of danazol on serum gonadotrophins and steroid hormone concentrations in women with menorrhagia

1 reference

12 December 2020

Treatment of functional menstrual disorders with norethisterone

1 reference

12 December 2020

Reversible trabecular bone density loss following induced hypo-oestrogenism with the GnRH analogue buserelin in premenopausal women

1 reference

12 December 2020

[The levonorgestrel intrauterine device]

1 reference

12 December 2020

Treatment of menorrhagia with meclofenamate sodium.

1 reference

12 December 2020

Incidence of ovulatory cycles in women approaching the menopause

1 reference

12 December 2020

An objective evaluation of flurbiprofen and tranexamic acid in the treatment of idiopathic menorrhagia

1 reference

12 December 2020

The effect of danazol on menorrhagia, coagulation mechanisms, haematological indices and body weight

1 reference

12 December 2020

Primary and myoma-associated menorrhagia: role of prostaglandins and effects of ibuprofen

1 reference

12 December 2020

Comparison between mefenamic acid and danazol in the treatment of established menorrhagia.

1 reference

12 December 2020

Tranexamic acid, intrauterine contraceptive devices and fatal cerebral arterial thrombosis. Case report.

1 reference

12 December 2020

Menstrual Blood Loss–A Population Study: Variation at different ages and attempts to define normality

1 reference

12 December 2020

Effect of fenamates on prostaglandin E receptor binding

1 reference

12 December 2020

Reduction of menstrual blood loss by danazol in unexplained menorrhagia: lack of effect of placebo

1 reference

12 December 2020

Use of a superactive luteinizing hormone releasing hormone (LHRH) agonist in the treatment of menorrhagia

1 reference

12 December 2020

Cerebral sinus thrombosis as a potential hazard of antifibrinolytic treatment in menorrhagia

1 reference

12 December 2020

Hysteroscopy with selective endometrial sampling compared with D&C for abnormal uterine bleeding: the value of a negative hysteroscopic view

1 reference

12 December 2020

A double-blind trial of ethamsylate in the treatment of primary and intrauterine-device menorrhagia

1 reference

12 December 2020

Treatment of menorrhagia with intrauterine release of progesterone

1 reference

12 December 2020

Critical assessment of dilatation and curettage in 1029 women

1 reference

12 December 2020

Relation between measured menstrual blood loss and patient's subjective assessment of loss, duration of bleeding, number of sanitary towels used, uterine weight and endometrial surface area.

1 reference

12 December 2020

Reduced menstrual blood loss by release of an antifibrinolytic agent from intrauterine contraceptive devices

1 reference

12 December 2020

Prostaglandin synthesis in the endometrium of women with ovular dysfunctional uterine bleeding

1 reference

12 December 2020

DETERMINATION OF MENSTRUAL BLOOD LOSS

1 reference

12 December 2020

Sources of variation in menstrual blood loss

1 reference

12 December 2020

An audit of abdominal hysterectomy over a decade in a district hospital

1 reference

12 December 2020

Prostaglandins in menstrual fluid in menorrhagia and dysmenorrhoea

1 reference

12 December 2020

Long-term treatment of menorrhagia with mefenamic acid.

1 reference

12 December 2020

Treatment of menorrhagia

1 reference

12 December 2020

Short-term effects of danazol on endometrial histology

1 reference

12 December 2020

The role of prostaglandins and allied substances in uterine haemostasis

1 reference

12 December 2020

A preliminary study of factors influencing perception of menstrual blood loss volume

1 reference

12 December 2020

The effects of danazol, mefenamic acid, norethisterone and a progesterone-impregnated coil on endometrial prostaglandin concentrations in women with menorrhagia

1 reference

12 December 2020

Noncontraceptive health benefits of oral steroidal contraceptives.

1 reference

12 December 2020

Variation of the human menstrual cycle through reproductive life

1 reference

12 December 2020

Leukotriene release by endometrium and myometrium throughout the menstrual cycle in dysmenorrhoea and menorrhagia

1 reference

12 December 2020

The effects of mefenamic acid and norethisterone on measured menstrual blood loss

1 reference

12 December 2020

Efficacy of mefenamic acid in patients with a complaint of menorrhagia

1 reference

12 December 2020

10.2165/00002018-199106030-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

19 August 2017

1023774232

0 references

1 reference